跳至主要内容
临床试验/IRCT20190804044429N2
IRCT20190804044429N2招募中2 期

Comparison of amantadine and dalfampridine efficacy in multiple sclerosis patients with fatigue

Mazandaran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Adult patients were aged more than 18 years
  • Patients with multiple sclerosis according to Mcdonald criteria 2017 and EDSS less than 5.5
  • MS patients with at least fatigue score of 33 according to MFIS

排除标准

  • Severe depression
  • Hypothyroidism
  • Severe anemia ( Hb‹ 9 g/dl)
  • Pregnancy or breast feeding
  • Ischemic heart disease or cardiovascular disease
  • Renal insufficiency
  • MS exacerbation within 30 days before
  • Uncontrolled blood pressure (BP more than 160/100 mm Hg)
  • use of other effective treatment on fatigue
  • Alcohol, recreational and substance abuse history
  • Monoamine oxidase inhibitors (MAOIs) use
  • Narcolepsy history
  • Psychosis history
  • Seizure history

研究者

相似试验